- Sorted by date
- Hybrid Sort
- Smart Random Sort
- Sort by relevance
Advertisements
» Related Searches: cancer, breast cancer, cancer risk, lung cancer treatment, prostate cancer
Results 21 to 30 of 68 
Bad news for top-selling anemia drugs
A new medical study suggests that high doses of a best- selling drug used to treat
anemia in dialysis and cancer patients may increase the risk of heart problems and … 
In brief
… cancer. The lab will start operations next May in temporary premises and then
build a larger facility, which, the Swiss drug company says, will eventually house
400 …
Doha Declaration on life-saving drugs for poor countries not happening
… drug, poor people in developing countries are still dying needlessly because
global pharmaceutical giants continue to monopolise drugs for diseases such as
cancer and AIDS …
Synta drug placed on fast track
Synta Pharmaceuticals Corp. said Wednesday that its drug candidate to treat a serious
type of skin cancer has been granted Fast Track designation by the U.S. Food and
Drug Administration …
Lung cancer drug more effective in Taiwanese patients
Filed under: Drug, Lung Cancer, Research, Daily news The lung cancer drug
Gefitinib has been taken off shelves in the United States due to ineffectiveness. But it
remains effective in …
Anti-cancer drug may be helpful in treating pulmonary hypertension
Washington, Nov 15 : Researchers at the University of Chicago say that a drug used to
treat kidney cancer may help prevent the development of pulmonary hypertension …
Heart Risk Seen in Drug for Anemia
A new study suggests that high doses of a best-selling drug used to treat anemia in
dialysis and cancer patients may increase the risk of heart problems …
Patients Respond Well To First Study To Test Higher Doses …
Researchers in the UK and the United States have found that a drug composed of an
antibody carrying a highly toxic anti-cancer agent is well tolerated by patients at
much …
- ├ Patients Respond Well To Higher Doses Of … — Health News from Medical News Today
- ├ Recurrent breast cancer: Drug shows promise — The Cancer Blog
- ├ Drug That Interrupts A Key Stage Of … — Health News from Medical News Today
- └ all 10 related »
First Berlin Releases Research Update Following Callisto Pharmaceutical's Announcement Of …
Callisto Pharmaceuticals, Inc. KAL (FWB:CA4), a developer of new drug treatments in
the fight against cancer and other major health threats, announced that a leading
independent research firm, First Berlin …
- ├ 1st Berlin Releases Research Update Following Callisto … — Pharmaceuticals News from StratCenter.com
- ├ CuraGen and TopoTarget Announce Initiation of NCI-Sponsored … — PR Newswire: All Releases
- ├ CuraGen, TopoTarget initiate ovarian cancer trial — Pharmaceutical Business Review Latest News
- └ all 10 related »
Enzyme Inhibitor Produces Stable Disease In Patients With Advanced Solid …
… drug inhibited key targets in the patients' tumours, and now it is being tested
in phase II clinical trials according to research presented at the 18th EORTC-NCI-AACR
Symposium on Molecular …
- ├ Enzyme Inhibitor Produces Stable Disease In Patients … — Health News from Medical News Today
- ├ Drug That Interrupts A Key Stage Of … — Health News from Medical News Today
- ├ Enzyme May Hold Key To New Treatment … — ScienceDaily Headlines: Health & Medicine
- └ all 10 related »